Ilaria Motta

3PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Behavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 29, 2025
Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis.

Lorenzo Guglielmetti, Uzma Khan, Gustavo E Velásquez

|Jun 06, 2024
How much should we still worry about QTc prolongation in rifampicin-resistant tuberculosis? ECG findings from TB-PRACTECAL clinical trial.

Ilaria Motta, Martina Cusinato, Andrew J Ludman

|Dec 22, 2022
A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis.

Bern-Thomas Nyang'wa, Catherine Berry, Emil Kazounis

Pageof 1